Home » Archive

Xconomy

Diagnostics, News, Syndication, Xconomy »

The Biotech IPO Scorecard: Who’s Up, Who’s Down in 2013

Posted by sandiegobiotech June 3rd, 2013 .
No Comments

Remember Plexxikon? The Berkeley, CA-based company had a lot of talent for structural biology-based drug design, an impressive new treatment for melanoma, and a strong management team. Two years ago,…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

There’s Less Pie in the Sky as Wireless Health Gets Connected

Posted by sandiegobiotech May 30th, 2013 .
No Comments

Attendance at the annual Wireless-Life Sciences Convergence Summit in San Diego has remained relatively steady in recent years (the first conference was held in 2006), but there has been a phase…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Juan Enriquez on the Forces Shaping Innovation: A Napa Summit Preview

Posted by sandiegobiotech May 21st, 2013 .
No Comments

What are the most powerful forces affecting innovation and the economy? That is one of the key questions facing the nation as we inch our way out of the economic mire. Juan Enriquez may not have all…

[[Click headline to continue reading.]]

More...

Conferences, News, Syndication, Xconomy »

Zillions of Biotech Conferences Want You. Which Should You Attend?

Posted by sandiegobiotech May 20th, 2013 .
No Comments

Biotech industry conferences are happening, somewhere on this green Earth, every day. If you’ve been around a while, and you’ve attended a few, chances are you get invitations, or marketing pitches,…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Ambit Slices Price of IPO, Increases Number of Shares Offered

Posted by sandiegobiotech May 16th, 2013 .
No Comments

San Diego’s Ambit Biosciences cut the share price of its planned IPO by nearly half yesterday, but still managed to raise about $65 million by increasing the number of shares in its debut offering….

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Ambit Slices Price of IPO, Increases Number of Shares Offered

Posted by sandiegobiotech May 16th, 2013 .
No Comments

San Diego’s Ambit Biosciences cut the share price of its planned IPO by nearly half yesterday, but still managed to raise about $65 million by increasing the number of shares in its debut offering….

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Henri Termeer on Startups, Drug Prices, Getting Older (Part 2)

Posted by sandiegobiotech May 14th, 2013 .
No Comments

Yesterday, we ran the first part of a wide-ranging interview with Henri Termeer, the legendary biotech entrepreneur and former CEO of Cambridge, MA-based Genzyme. He spoke about what kinds of…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)

Posted by sandiegobiotech May 13th, 2013 .
No Comments

Henri Termeer could have easily faded away into obscurity a couple years ago. The biotech pioneer could have relaxed at his oceanside home in Maine, played a little golf. Or, if he wanted, he could…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Receptos, Arena, NuVasive, & More

Posted by sandiegobiotech May 9th, 2013 .
No Comments

Amid the hectic pace of earnings releases, we saw a number of partnership agreements and other developments coming out of San Diego’s life sciences community.  Here’s my wrap-up. —Shares of San…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

San Diego’s Receptos, Ambit Biosciences, Get Ready for IPO Debuts

Posted by sandiegobiotech May 6th, 2013 .
No Comments

[Corrected 5/6/13, 10:50 am. See below.] San Diego-based Receptos, a biotech developing new treatments for immune disorders, is among 13 IPOs expected to go public this week, according to Renaissance…

[[Click headline to continue reading.]]

More...